Press "Enter" to skip to content

New patent for Glaxosmithkline drug ANORO ELLIPTA

0
Copyright © DrugPatentWatch. Originally published at New patent for Glaxosmithkline drug ANORO ELLIPTA

Annual Drug Patent Expirations for ANORO+ELLIPTA
Annual Drug Patent Expirations for ANORO+ELLIPTA

Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

ANORO ELLIPTA drug price trends.

This drug has two hundred and ninety-nine patent family members in forty-seven countries.

The generic ingredient in ANORO ELLIPTA is umeclidinium bromide; vilanterol trifenatate. One supplier is listed for this compound. Additional details are available on the umeclidinium bromide; vilanterol trifenatate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Glaxosmithkline drug ANORO ELLIPTA
DrugPatentWatch - Make Better Decisions